A Flexible Regression Modeling Approach Applied to Observational Laboratory Virological Data Suggests That SARS-CoV-2 Load in Upper Respiratory Tract Samples Changes with COVID-19 Epidemiology.

Kaplan–Meier curve SARS-CoV-2 load quantile regression regression modeling approach upper respiratory tract vaccination

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
23 09 2023
Historique:
received: 04 07 2023
revised: 12 09 2023
accepted: 19 09 2023
medline: 30 10 2023
pubmed: 28 10 2023
entrez: 28 10 2023
Statut: epublish

Résumé

(1) Background. Exploring the evolution of SARS-CoV-2 load and clearance from the upper respiratory tract samples is important to improving COVID-19 control. Data were collected retrospectively from a laboratory dataset on SARS-CoV-2 load quantified in leftover nasal pharyngeal swabs (NPSs) collected from symptomatic/asymptomatic individuals who tested positive to SARS-CoV-2 RNA detection in the framework of testing activities for diagnostic/screening purpose during the 2020 and 2021 winter epidemic waves. (2) Methods. A Statistical approach (quantile regression and survival models for interval-censored data), novel for this kind of data, was applied. We included in the analysis SARS-CoV-2-positive adults >18 years old for whom at least two serial NPSs were collected. A total of 262 SARS-CoV-2-positive individuals and 784 NPSs were included: 193 (593 NPSs) during the 2020 winter wave (before COVID-19 vaccine introduction) and 69 (191 NPSs) during the 2021 winter wave (all COVID-19 vaccinated). We estimated the trend of the median value, as well as the 25th and 75th centiles of the viral load, from the index episode (i.e., first SARS-CoV-2-positive test) until the sixth week (2020 wave) and the third week (2021 wave). Interval censoring methods were used to evaluate the time to SARS-CoV-2 clearance (defined as Ct < 35). (3) Results. At the index episode, the median value of viral load in the 2021 winter wave was 6.25 log copies/mL (95% CI: 5.50-6.70), and the median value in the 2020 winter wave was 5.42 log copies/mL (95% CI: 4.95-5.90). In contrast, 14 days after the index episode, the median value of viral load was 3.40 log copies/mL (95% CI: 3.26-3.54) for individuals during the 2020 winter wave and 2.93 Log copies/mL (95% CI: 2.80-3.19) for those of the 2021 winter wave. A significant difference in viral load shapes was observed among age classes (

Identifiants

pubmed: 37896765
pii: v15101988
doi: 10.3390/v15101988
pmc: PMC10610845
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0
RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

BMC Med. 2022 Jan 13;20(1):25
pubmed: 35022051
Biometrika. 2011 Dec;98(4):995-999
pubmed: 23049133
Infect Dis (Lond). 2021 Nov;53(11):876-879
pubmed: 34176397
Nat Med. 2021 Jan;27(1):28-33
pubmed: 33442016
Clin Infect Dis. 2020 Nov 19;71(16):2252-2254
pubmed: 32435816
N Engl J Med. 2021 Dec 23;385(26):2489-2491
pubmed: 34941024
JMIR Public Health Surveill. 2020 Dec 16;6(4):e23624
pubmed: 33259325
Lancet Infect Dis. 2022 Jan;22(1):16
pubmed: 34953540
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061
pubmed: 32342252
Elife. 2021 Jul 12;10:
pubmed: 34250907
JAMA Netw Open. 2022 Aug 1;5(8):e2228008
pubmed: 35994285
EBioMedicine. 2020 Aug;58:102916
pubmed: 32711256
Viruses. 2022 Feb 04;14(2):
pubmed: 35215916
Microbiol Insights. 2022 Mar 23;15:11786361221087537
pubmed: 35341107
Lancet Infect Dis. 2022 Feb;22(2):183-195
pubmed: 34756186
JAMA. 2022 Oct 18;328(15):1523-1533
pubmed: 36255426
Nat Rev Immunol. 2022 Jan;22(1):57-65
pubmed: 34876702
Rev Med Virol. 2022 Jul;32(4):e2313
pubmed: 34755408
Nat Med. 2022 Jul;28(7):1491-1500
pubmed: 35395151
Viruses. 2022 Apr 28;14(5):
pubmed: 35632661
Nat Med. 2022 Aug;28(8):1715-1722
pubmed: 35710987
Open Forum Infect Dis. 2022 Apr 13;9(7):ofac192
pubmed: 35791353
J Infect Dis. 2022 Mar 2;225(5):793-799
pubmed: 34865022
J Clin Epidemiol. 2009 May;62(5):511-7.e1
pubmed: 19135859
Elife. 2021 Feb 05;10:
pubmed: 33543709
MMWR Morb Mortal Wkly Rep. 2021 Aug 06;70(31):1059-1062
pubmed: 34351882
JAMA. 2020 Aug 4;324(5):441-442
pubmed: 32749495
Proc Natl Acad Sci U S A. 2021 Feb 23;118(8):
pubmed: 33536313
Eur J Hum Genet. 2022 Aug;30(8):908-914
pubmed: 35768520
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168

Auteurs

Laura Pellegrinelli (L)

Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.

Ester Luconi (E)

Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, 20133 Milan, Italy.

Giuseppe Marano (G)

Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, 20133 Milan, Italy.

Cristina Galli (C)

Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.

Serena Delbue (S)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20133 Milan, Italy.

Laura Bubba (L)

Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.

Sandro Binda (S)

Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.

Silvana Castaldi (S)

Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Elia Biganzoli (E)

Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, 20133 Milan, Italy.
Data Science and Research Center (DSRC), L. Sacco, "Luigi Sacco" University Hospital, University of Milan, 20133 Milan, Italy.

Elena Pariani (E)

Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.

Patrizia Boracchi (P)

Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, 20133 Milan, Italy.
Data Science and Research Center (DSRC), L. Sacco, "Luigi Sacco" University Hospital, University of Milan, 20133 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH